Brooklyn Investment Group’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$246K Buy
2,084
+288
+16% +$40.2K 0.01% 1575
2025
Q4
$298K Buy
+1,796
New +$281K 0.01% 1045
2025
Q3
Sell
-370
Closed -$46K 2225
2025
Q2
$46K Buy
370
+267
+259% +$34K 0.01% 1381
2025
Q1
$13.1K Buy
103
+45
+78% +$6.93K ﹤0.01% 1388
2024
Q4
$8.35K Buy
58
+2
+4% +$287 ﹤0.01% 1052
2024
Q3
$8.33K Buy
+56
New +$8.03K ﹤0.01% 805

Other funds holding RGEN

Brooklyn Investment Group's RGEN Position: Q1 2026 in Review

Brooklyn Investment Group increased its Repligen (RGEN) stake by 16% in Q1 2026, buying an estimated $40.2K and bringing the position to 2,084 shares worth $246K. The position accounts for 0.01% of the portfolio, ranked #1575.

Brooklyn Investment Group first reported a position in RGEN in Q3 2024 and has held it in 6 quarters since. The position peaked at $298K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Brooklyn Investment Group held 2,084 shares of Repligen worth $246K as of Q1 2026.
  • Brooklyn Investment Group bought 288 Repligen shares in Q1 2026, an estimated $40.2K.
  • Repligen made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1575 holding.
  • Brooklyn Investment Group first reported a position in Repligen in Q3 2024 and has held it in 6 quarters since.
  • Brooklyn Investment Group's Repligen position peaked at $298K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.